Frontiers in Molecular Biosciences (Jun 2015)
MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics
Abstract
Sarcomas are highly aggressive heterogeneous tumors that are mesenchymal in origin. There have been vast advancements on identifying diagnostic markers for sarcomas including chromosomal translocations, but very little progress has been made to identify targeted therapies against them. The tumor heterogeneity, genetic complexity and the lack of drug studies make it challenging to recognize the potential targets and also accounts for the inadequate treatments in sarcomas. In recent years, microRNAs that are a part of small non-coding RNAs have shown promising results as potential diagnostic and prognostic biomarkers in multiple sarcoma types. This review focuses on the current knowledge of the microRNAs that are deregulated in the sarcoma, and an insight on the strategies to target these microRNAs that are essential for developing improved therapies for various human sarcomas.
Keywords
